PuraMatrix® has demonstrated efficacy in multiple models for hemostasis (CE Mark approved, trade name PuraStat®), tissue regeneration, acute myocardial infarction, therapeutic protein and stem cell delivery, and CNS injury. PuraMatrix® can re-hydrate and provide mechanical support for disc height collapse in degenerated IVDs, anti-adhesion, polyp resection, and bone formation. PuraMatrix® has also been used to repair and restore visual function in the CNS after damage.
PuraMatrix® is an injectable, flowable bone regeneration scaffold. There are numerous opportunities for which PuraMatrix® may be used in combination with many commercially-available orthopedic medical devices and/or products:
Click here for peer-reviewed publications of PuraMatrix® in Bone and Cartilage Regeneration clinical applications.